Upcoming HealthVerity Event on RWD in Rare Disease Drug Development Pipeline
May 20, 2021
Using real world data (RWD) in rare disease research offers a method to circumvent many of the traditional challenges facing researchers. HealthVerity will hold a live event on May 27th at 12:00 PM EDT featuring insight on RWD sources and select cases where RWD was used to draw important conclusions.
“In the United States, a disease is considered rare if it affects less than 200,000 individuals, so researching and developing treatments for this population is extremely challenging. In fact, 95% of rare diseases lack an FDA-approved product for treatment. Consequently, the need for information about rare diseases and the people they impact is greater than ever. By adding real-world data to the equation, researchers and developers can create a truly longitudinal patient journey, rich with insights ranging from diagnosis through to treatment, post-surgical care and more.” Register here.
(Source: HealthVerity, 2021)